haloperidol has been researched along with Hebephrenic Schizophrenia in 15 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of this study was to examine the antipsychotic effect and side effect profile of amoxapine versus haloperidol in a double-blind study for 6 weeks in patients with schizophrenia." | 5.12 | Amoxapine as an antipsychotic: comparative study versus haloperidol. ( Badshah, S; Chaudhry, IB; Deakin, B; Husain, N; Kapur, S; Khan, S, 2007) |
| "Treatment with risperidone solution orally or parenteral haloperidol until the day after admission, followed by olanzapine, successfully improved the clinical condition of the patients." | 1.35 | Three cases of schizophrenia for which olanzapine was effective after early acute phase. ( Inada, T; Oda, T; Yamamoto, N, 2008) |
| "Schizophrenia Care and Assessment Program, a large, prospective study of treatment for schizophrenia conducted July 1997 through September 2003." | 1.34 | Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. ( Ascher-Svanum, H; Faries, D; Marder, SR; Montgomery, W; Shi, L; Zhu, B, 2007) |
| "Haloperidol was given for 30 days, at a daily dose of 6 mg i." | 1.25 | Growth hormone secretion in chronic schizophrenia. ( Brambilla, F; Guastalla, A; Guerrini, A; Recchia, M; Riggi, F; Rovere, C, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, L | 1 |
| Ascher-Svanum, H | 1 |
| Zhu, B | 1 |
| Faries, D | 1 |
| Montgomery, W | 1 |
| Marder, SR | 1 |
| Brambilla, F | 5 |
| Guerrini, A | 5 |
| Riggi, F | 5 |
| Ricciardi, F | 1 |
| Chaudhry, IB | 1 |
| Husain, N | 1 |
| Khan, S | 1 |
| Badshah, S | 1 |
| Deakin, B | 1 |
| Kapur, S | 1 |
| Yamamoto, N | 1 |
| Oda, T | 1 |
| Inada, T | 1 |
| Rovere, C | 4 |
| Guastalla, A | 4 |
| Burbati, G | 1 |
| Cassano, GB | 1 |
| Castrogiovanni, P | 1 |
| Conti, L | 1 |
| Bonollo, L | 1 |
| Kay, SR | 1 |
| Singh, MM | 2 |
| Itil, TM | 1 |
| Marasa, J | 1 |
| Saletu, B | 1 |
| Davis, S | 1 |
| Mucciardi, AN | 1 |
| Recchia, M | 1 |
| Zanoboni, A | 1 |
| Zanoboni-Muciaccia, W | 1 |
| Bersani, G | 1 |
| Valeri, M | 1 |
| Bersani, I | 1 |
| Piazza, A | 1 |
| Adorno, D | 1 |
| Casciani, CU | 1 |
| Ciani, N | 1 |
| Gattaz, WF | 1 |
| Rost, W | 1 |
| Hübner, CK | 1 |
| Bauer, K | 1 |
| Altamura, AC | 1 |
| Mauri, MC | 1 |
| Mantero, M | 1 |
| Brunetti, M | 1 |
7 trials available for haloperidol and Hebephrenic Schizophrenia
| Article | Year |
|---|---|
Amoxapine as an antipsychotic: comparative study versus haloperidol.
Topics: Adolescent; Adult; Age Factors; Amoxapine; Antidepressive Agents, Second-Generation; Antipsychotic A | 2007 |
Effects of clomiphene citrate administraiton on the hypothalamo-pituitary-gonadal axis of male chronic schizophrenics.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clomiphene; Follicle Stimulating Hormone; Hal | 1977 |
Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
Topics: Adult; Aged; Analysis of Variance; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Compute | 1975 |
Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
Topics: Adult; Anxiety; Chlorpromazine; Clinical Trials as Topic; Female; Haloperidol; Humans; Longitudinal | 1976 |
Computerized EEG: predictor of outcome in schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Computers; Drug Resistance; Electroencephalography | 1975 |
Acute and subchronic effects of low-dose bromocriptine in haloperidol-treated schizophrenics.
Topics: Adult; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Metho | 1989 |
Clonazepam/haloperidol combination therapy in schizophrenia: a double blind study.
Topics: Adult; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Female; | 1987 |
8 other studies available for haloperidol and Hebephrenic Schizophrenia
| Article | Year |
|---|---|
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
Topics: Administration, Oral; Adult; Alcoholism; Antipsychotic Agents; Black People; Cohort Studies; Comorbi | 2007 |
Psychoendocrine investigation in schizophrenia: relationship between pituitary-gonadal function and behavior.
Topics: Adult; Antipsychotic Agents; Behavior; Chorionic Gonadotropin; Drug Therapy, Combination; Haloperido | 1974 |
Three cases of schizophrenia for which olanzapine was effective after early acute phase.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Foll | 2008 |
Neuroendocrine effects of haloperidol therapy in chronic schizophrenia.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Blood Gl | 1975 |
Cognitive abnormality in schizophrenia: a dual-process model.
Topics: Adolescent; Adult; Arousal; Attention; Chlorpromazine; Cognition Disorders; Color Perception; Concep | 1979 |
Growth hormone secretion in chronic schizophrenia.
Topics: Adolescent; Adult; Chronic Disease; Female; Growth Hormone; Haloperidol; Humans; Insulin; Male; Midd | 1975 |
Glucose-insulin metabolism in chronic schizophrenia.
Topics: Adult; Blood Glucose; Diabetes Complications; Glucose; Glucose Tolerance Test; Haloperidol; Humans; | 1976 |
HLA antigens and neuroleptic response in clinical subtypes of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Chromosome Mapping; Female; Gene Frequency; Haloperidol; HLA-A | 1989 |